Risk Factors for De Novo Malignancy Following Lung Transplantation.

Area of Science:

• Oncology
• Transplantation Medicine
• Epidemiology

Background:

• Lung transplantation is a life-saving procedure for end-stage lung disease.
• The long-term risk of developing new cancers (de novo malignancies) after lung transplantation is not well-defined.
• Identifying risk factors for these cancers is crucial for patient management and outcomes.

Purpose of the Study:

• To identify risk factors for non-skin cancer de novo malignancy (DNM) after lung transplantation.
• To determine the incidence and types of DNM following lung transplantation.
• To assess the impact of DNM on post-transplant mortality.

Main Methods:

• Utilized the United Network for Organ Sharing database for adult lung transplant patients (1989-2012).
• Calculated standardized incidence ratios (SIRs) by comparing to Surveillance, Epidemiology, and End Results Program data, excluding non-melanoma skin cancers.
• Performed multivariable survival analysis to identify predictors of DNM and its association with mortality.

Main Results:

• Identified 18,093 adult lung transplant patients with a median follow-up of 1086 days.
• Observed DNMs in 1306 patients, with 1, 3, and 5-year incidences of 1.4%, 4.6%, and 7.9%, respectively.
• Overall cancer incidence was 3.26 times higher than the general population; common cancers included lung cancer (SIR 6.49) and lymphoproliferative disease (SIR 14.14).
• Predictors of DNM included older age, male gender, non-cystic fibrosis/idiopathic pulmonary fibrosis/interstitial lung disease etiology, and single-lung transplantation.
• DNMs were associated with a 1.44-fold increased risk of mortality.

Conclusions:

• Lung transplant recipients have a significantly elevated risk of developing de novo malignancies compared to the general population.
• Age, male gender, specific disease etiologies, and single-lung transplantation are significant predictors of DNM.
• De novo malignancies following lung transplantation are associated with increased mortality, highlighting the need for vigilant surveillance and risk factor management.